These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 33738588)
41. Updates in colorectal cancer stem cell research. Li CJ; Zhang X; Fan GW J Cancer Res Ther; 2014 Dec; 10 Suppl():233-9. PubMed ID: 25693926 [TBL] [Abstract][Full Text] [Related]
42. Stem cell programs in cancer initiation, progression, and therapy resistance. Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274 [TBL] [Abstract][Full Text] [Related]
43. Knockdown of hnRNPAB reduces the stem cell properties and enhances the chemosensitivity of human colorectal cancer stem cells. Zhou J; Chen S; Liu J; Du J; Li J Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165920 [TBL] [Abstract][Full Text] [Related]
44. Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs. Rao GH; Liu HM; Li BW; Hao JJ; Yang YL; Wang MR; Wang XH; Wang J; Jin HJ; Du L; Chen Q Acta Pharmacol Sin; 2013 Jun; 34(6):793-804. PubMed ID: 23736004 [TBL] [Abstract][Full Text] [Related]
45. Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells. Quarni W; Dutta R; Green R; Katiri S; Patel B; Mohapatra SS; Mohapatra S Sci Rep; 2019 Oct; 9(1):15202. PubMed ID: 31645574 [TBL] [Abstract][Full Text] [Related]
46. CD133: An emerging prognostic factor and therapeutic target in colorectal cancer. Akbari M; Shomali N; Faraji A; Shanehbandi D; Asadi M; Mokhtarzadeh A; Shabani A; Baradaran B Cell Biol Int; 2020 Feb; 44(2):368-380. PubMed ID: 31579983 [TBL] [Abstract][Full Text] [Related]
47. Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells. Shirmohamadi M; Eghbali E; Najjary S; Mokhtarzadeh A; Kojabad AB; Hajiasgharzadeh K; Lotfinezhad P; Baradaran B J Cell Physiol; 2020 Feb; 235(2):776-789. PubMed ID: 31264216 [TBL] [Abstract][Full Text] [Related]
48. Primary cultures of human colon cancer as a model to study cancer stem cells. Koshkin S; Danilova A; Raskin G; Petrov N; Bajenova O; O'Brien SJ; Tomilin A; Tolkunova E Tumour Biol; 2016 Sep; 37(9):12833-12842. PubMed ID: 27449036 [TBL] [Abstract][Full Text] [Related]
49. Possible Role of Cancer Stem Cells in Colorectal Cancer Metastasizing to the Liver. Jiao ZY; Cao HT; Li YM Curr Stem Cell Res Ther; 2016; 11(5):440-3. PubMed ID: 26832139 [TBL] [Abstract][Full Text] [Related]
50. Therapeutic approaches targeting cancer stem cells. Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025 [TBL] [Abstract][Full Text] [Related]
51. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs. Zhao Y; Li Y; Sheng J; Wu F; Li K; Huang R; Wang X; Jiao T; Guan X; Lu Y; Chen X; Luo Z; Zhou Y; Hu H; Liu W; Du B; Miao S; Cai J; Wang L; Zhao H; Ying J; Bi X; Song W J Exp Clin Cancer Res; 2019 Aug; 38(1):379. PubMed ID: 31455383 [TBL] [Abstract][Full Text] [Related]
52. Intratumoral functional heterogeneity and chemotherapy. Sipos F; Constantinovits M; Műzes G World J Gastroenterol; 2014 Mar; 20(10):2429-32. PubMed ID: 24627580 [TBL] [Abstract][Full Text] [Related]
53. Exploiting bioactive natural products of marine origin: Evaluation of the meroterpenoid metachromin V as a novel potential therapeutic drug for colorectal cancer. Lucchetti D; Luongo F; Colella F; Gurreri E; Artemi G; Desiderio C; Serra S; Giuliante F; De Maria R; Sgambato A; Vitali A; Fiori ME Biomed Pharmacother; 2023 Jun; 162():114679. PubMed ID: 37068332 [TBL] [Abstract][Full Text] [Related]
54. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells. Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066 [TBL] [Abstract][Full Text] [Related]
55. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways. Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243 [TBL] [Abstract][Full Text] [Related]
56. The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance. Chen K; Zhang C; Ling S; Wei R; Wang J; Xu X Cell Death Dis; 2021 Sep; 12(9):835. PubMed ID: 34482364 [TBL] [Abstract][Full Text] [Related]
57. Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer. Sogawa C; Eguchi T; Namba Y; Okusha Y; Aoyama E; Ohyama K; Okamoto K Cells; 2021 Feb; 10(2):. PubMed ID: 33562088 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA: A new player in response to therapy for colorectal cancer. Sarvizadeh M; Malekshahi ZV; Razi E; Sharifi H; Moussavi N; Taghizadeh M J Cell Physiol; 2019 Jun; 234(6):8533-8540. PubMed ID: 30478837 [TBL] [Abstract][Full Text] [Related]
59. Sphere‑forming assay vs. organoid culture: Determining long‑term stemness and the chemoresistant capacity of primary colorectal cancer cells. Zhao H; Yan C; Hu Y; Mu L; Huang K; Li Q; Li X; Tao D; Qin J Int J Oncol; 2019 Mar; 54(3):893-904. PubMed ID: 30664193 [TBL] [Abstract][Full Text] [Related]
60. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma. Kumar D; Gorain M; Kundu G; Kundu GC Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]